Literature DB >> 26618441

Predicting adherence trajectory using initial patterns of medication filling.

Jessica M Franklin1, Alexis A Krumme, William H Shrank, Olga S Matlin, Troyen A Brennan, Niteesh K Choudhry.   

Abstract

OBJECTIVES: To evaluate the ability of initial medication dispensings to predict long-term patterns of adherence. STUDY
DESIGN: A retrospective cohort study of statin initiators enrolled in a Medicare Part D drug plan from CVS Caremark from 2005 to 2008.
METHODS: We used group-based trajectory models to classify patients into 6 adherence trajectories based on patterns of statin filling over the year following therapy initiation. Baseline clinical characteristics and indicators of statin filling during the first 2 to 4 months following initiation were used to predict adherence trajectory in logistic regression models, separately within strata of the days' supply of the initial statin dispensing. Cross-validation was used to measure predictive accuracy of models in data not used for model estimation.
RESULTS: Among 77,703 statin initiators, prediction using baseline variables only was poor (cross-validated C statistic ≤ 0.61). When using 3 months of initial adherence to predict trajectory, prediction was greatly improved among patients with an index supply ≤30 days (0.62 ≤ C ≤ 0.91). With 4 months of initial adherence in the model, prediction was strong for all patients (C ≥ 0.72), especially for the best and worst trajectories (C = 0.90 and 0.94, respectively, in patients with an index supply ≤ 30 days; and C = 0.83 and 0.90, respectively, in patients with an index supply > 30 days).
CONCLUSIONS: Initial filling behavior strongly predicted future adherence trajectory. Predicting adherence trajectories may facilitate better targeting of interventions to patients most likely to benefit.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26618441

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  15 in total

1.  Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.

Authors:  Jennifer L Hargrove; Virginia Pate; Carri H Casteel; Yvonne M Golightly; Laura R Loehr; Stephen W Marshall; Til Stürmer
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

2.  Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial.

Authors:  Niteesh K Choudhry; Alexis A Krumme; Patrick M Ercole; Charmaine Girdish; Angela Y Tong; Nazleen F Khan; Troyen A Brennan; Olga S Matlin; William H Shrank; Jessica M Franklin
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

3.  Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.

Authors:  Ilana Graetz; Caitlin N McKillop; Edward Stepanski; Gregory A Vidal; Janeane N Anderson; Lee S Schwartzberg
Journal:  J Cancer Surviv       Date:  2018-02-28       Impact factor: 4.442

4.  Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries.

Authors:  Chelsea E Hawley; Julie C Lauffenburger; Julie M Paik; Deborah J Wexler; Seoyoung C Kim; Elisabetta Patorno
Journal:  Diabetes Care       Date:  2022-03-01       Impact factor: 19.112

5.  Targeted Adherence Intervention to Reach Glycemic Control with Insulin Therapy for patients with Diabetes (TARGIT-Diabetes): rationale and design of a pragmatic randomised clinical trial.

Authors:  Jennifer Lewey; Wenhui Wei; Julie C Lauffenburger; Sagar Makanji; Alan Chant; Jeff DiGeronimo; Gina Nanchanatt; Saira Jan; Niteesh K Choudhry
Journal:  BMJ Open       Date:  2017-10-30       Impact factor: 2.692

6.  Group-Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting.

Authors:  Paul Dillon; Derek Stewart; Susan M Smith; Paul Gallagher; Gráinne Cousins
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

7.  Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study.

Authors:  Tingting Zhang; Elaine Kingwell; Feng Zhu; John Petkau; Lorne F Kastrukoff; Ruth Ann Marrie; Helen Tremlett; Charity Evans
Journal:  BMJ Open       Date:  2017-09-29       Impact factor: 2.692

8.  Retrospective interrupted time series examining hypertension and diabetes medicines usage following changes in patient cost sharing in the 'Farmácia Popular' programme in Brazil.

Authors:  Isabel Cristina Martins Emmerick; Monica Rodrigues Campos; Vera Lucia Luiza; Luisa Arueira Chaves; Andrea Dâmaso Bertoldi; Dennis Ross-Degnan
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

9.  Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs).

Authors:  Rutugandha Paranjpe; Michael L Johnson; Ekere J Essien; Jamie C Barner; Omar Serna; Esteban Gallardo; Zahra Majd; Marc L Fleming; Nancy Ordonez; Marcia M Holstad; Susan M Abughosh
Journal:  Patient Prefer Adherence       Date:  2020-10-13       Impact factor: 2.711

10.  Not there yet: using data-driven methods to predict who becomes costly among low-cost patients with type 2 diabetes.

Authors:  Julie C Lauffenburger; Mufaddal Mahesri; Niteesh K Choudhry
Journal:  BMC Endocr Disord       Date:  2020-08-17       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.